Drug profile · INN
apraclonidine hydrochloride
IOPIDINE
apraclonidine hydrochloride (IOPIDINE) is a adrenergic receptor alpha-2 agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — apraclonidine hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
apraclonidine hydrochloride (IOPIDINE) is a adrenergic receptor alpha-2 agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-2 agonist
Primary target: Adrenergic receptor alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is apraclonidine hydrochloride?
apraclonidine hydrochloride (IOPIDINE) is a adrenergic receptor alpha-2 agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for apraclonidine hydrochloride?
IOPIDINE is a marketed brand name for apraclonidine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of apraclonidine hydrochloride?
apraclonidine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.